✨
AI Summary
- Jim Otvos discusses developing a new lipoprotein measurement from a flawed cancer test.
- Learn why LDL-P and apoB offer insights beyond standard cholesterol tests.
- Understand that large LDL particles are not necessarily benign and can indicate risk.